osimertinib
astrazeneca
['adaura']
the #oncoalerttoptweet #esmo22 day 3 tweet adaura update. still striking, however waning dfs benefits were presented by dr. tsuboi. step by step, the issues are becoming clearer, yet many questions remain unanswered. best, 
?? Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees ?? We are #OncoAlert ??